Washington, D.C. Health Sector News: Bipartisan Efforts and Regulatory Updates

Health Dose: A Comprehensive Weekly Update on Washington, D.C. Health Sector Developments

In this week’s edition of Holland & Knight Health Dose, we bring you the latest updates from Washington, D.C. on issues impacting the health sector. Our coverage includes bipartisan efforts in the Senate Finance Committee to draft a GME bill, legislation aimed at prohibiting biotechnology contracting with foreign adversaries, and a resolution filed by Sen. Paul on Laboratory Developed Tests.

Other topics discussed in this week’s Health Dose include Congress members requesting expanded coverage for digital therapeutics, a bipartisan group of legislators on the E&C Health Subcommittee introducing 340B legislation, and the release of a prior authorization report at the request of Rep. Pallone. Additionally, the Senate HELP Committee approved six measures, there were House hearings on healthcare consolidation, and a new Preventive Health Caucus was formed.

As always, our update includes information on congressional retirements and resignations as well as updates from regulatory agencies such as the FDA on AI guidance to address data quality, transparency, and standard definitions. The NIH released a proposal and Request for Information on equitable and affordable access to research resources while there was also a reversal in OCR guidance and CMS announced an expansion of its Oncology Model program.

To stay informed about these developments and more, be sure to visit our website for the full edition of Holland & Knight Health Dose.